PACS (PACS)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from PACS's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from PACS's 10-K filings. The deep dive has 15+ years, quarters and every line.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $2.4B | $3.1B | $4.1B | $5.3B |
| Net income | $150M | $113M | $56M | $192M |
| Free cash flow | — | — | — | — |
| EPS (diluted) | $1.17 | $0.88 | $0.38 | $1.22 |
| Operating margin | 9.6% | 6.7% | 3.0% | 5.9% |
Superinvestors who own PACS
From each investor's latest 13F filing (what a 13F shows). 1 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Cliff Asness AQR Capital Management |
Trimmed | $5M | 0.00% | Q2 2026 |
Insider buying
Open-market purchases by PACS's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Nov 24, 2025 | Evelyn S Dilsaver |
16,724 | $29.90 | $500,048 |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when PACS trades at or below it.
Free accounts get 3 price alerts. No card needed.
In the full deep dive
Questions
Are PACS insiders buying the stock?
1 open-market insider purchase of PACS in the last 12 months, from SEC Form 4 filings.
Which superinvestors own PACS?
1 of the superinvestors Investingly tracks hold PACS in their latest 13F, including Cliff Asness.
Prices and ratios as of Oct 7, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.